Evidence map›Paper›PMID 36142639›Full record

ArticleInternational journal of molecular sciences2022

Higher Na

Simon Thibault, Valérie Long, Céline Fiset

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. An In Vivo Model of Estrogen Supplementation Concerning the Expression of CaJournal of cardiovascular development and disease · 2024
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Simon ThibaultResearch Center, Montreal Heart Institute, Montréal, QC H1T 1C8, Canada.
Valérie LongResearch Center, Montreal Heart Institute, Montréal, QC H1T 1C8, Canada.
Céline FisetResearch Center, Montreal Heart Institute, Montréal, QC H1T 1C8, Canada.ORCID 0000-0003-2309-4823
Montreal Heart Institute · CA

Funding

CIHR PJT-153069
6 · The paper itself

Abstract

Male sex is one of the most important risk factors of atrial fibrillation (AF), with the incidence in men being almost double that in women. However, the reasons for this sex difference are unknown. Accordingly, in this study, we sought to determine whether there are sex differences in intracellular Ca

Indexed as

Atrial FibrillationAnimalsCalciumChelating AgentsEgtazic AcidFemaleHeart AtriaHumansMaleMiceMyocytes, CardiacPatch-Clamp TechniquesSarcoplasmic ReticulumSex CharacteristicsSodium-Calcium Exchanger1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidCalciumChelating AgentsEgtazic AcidNCX1 protein, mouseSodium-Calcium Exchangeratrial fibrillationCa2+ transientL-type Ca2+ currentNa+-Ca2+ exchangersex differences

Identifiers

PMID36142639
PMCPMC9501955
OpenAlexW4295780025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.